Scott D. Ramsey
Statistics and Probability · 2001–2016
A researcher in the Science corpus: 7 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Statistics and Probability — 19 citations into it
Whom Scott D. Ramsey trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Scott D. Ramsey overall
Papers from Scott D. Ramsey's perspective
Ordered by how strongly the researchers Scott D. Ramsey trusts endorse each paper. Same corpus, a different order for every researcher.
- Observational Studies
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
- Representing uncertainty: the role of cost-effectiveness acceptability curves. (Health Economics)
- Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. (Value in Health)
- The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. (The Oncologist)
- Washington Cancer Patients Found To Be At Greater Risk For Bankruptcy Than People Without A Cancer Diagnosis (Health Affairs)
- Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. (Journal of Clinical Oncology)
- Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. (Gastroenterology)
- Using Propensity Scores to Help Design Observational Studies: Application to the Tobacco Litigation
- The central role of the propensity score in observational studies for causal effects
Their papers
- Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. (2005) — 728 citations
- Washington Cancer Patients Found To Be At Greater Risk For Bankruptcy Than People Without A Cancer Diagnosis (2013) — 673 citations
- Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer. (2016) — 752 citations
- Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report. (2015) — 705 citations
- Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. (2004) — 3,213 citations
- Early detection: The case for early detection (2003) — 702 citations
- Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial. (2001) — 1,141 citations